Proposed is a prospective dynamic cohort to determine the prevalence and incidence of HIV in recently initiated adolescent and young adult injection drug users or initiates, and adolescent and young adult noninjection drug users or NlUs (heroin/cocaine sniffers, crack smokers) and to identify correlates and risk factors of HIV infection which include newly examined factors in the presence of previously identified HIV risk behaviors. For this proposal, the """"""""new"""""""" variables will include physical/sexual abuse, psychiatric condition, social networks/social support; the established variables include demographics, drug use and sex practices, and circumstances of initiation into injecting Eligible initiates must be between the ages of 15-30 and have initiated injection drug use with the past 5 years. Eligible NIUs must also be between the ages of 15-30 and have used drugs (snort heroin/cocaine or smoke crack) between 1 and 10 years prior to enrollment. The 400 young initiates and 200 young NIUs will be recruited using street outreach methodology which will involve a stationary clinic and mobile clinic for screening, interviewing, testing and follow-up in the Greater Baltimore City area. This dynamic cohort recruited and enrolled over a 5-year study period will undergo baseline, 6, and 12-month interviews along with HIV testing of all eligible participants of whom moderate remunerations will be given. Blood drawn on all participants will be screened for HIV using ELISA and Western Blot assays, and stored in a repository for later testing of other blood-borne pathogens. In addition to the HIV results, other data collected during the interview will include the above mentioned """"""""established"""""""" correlates and """"""""new"""""""" correlates (e.g., physical/sexual abuse, psychiatric condition and social network/social support). The above correlates will be compared and contrasted among initiates and NlUs. A transition rate (from noninjection to injection drug use) by the above covariates will also be estimated. The analysis will include a cross-sectional assessment of baseline data using univariate and bivariate approaches such as 2x2 and 2xK tables confirmed with Mantel-Haenszel techniques. Multivariate analysis will use logistic regression and regression tree techniques. Prospective data on HIV incidence will use person-time techniques for univariate and poisson regression for multivariate analyses Cox regression may also be employed when examining transition rates by selected covariates. We are interested in identifying and clarifying the independent and joint effects of the variables that relate to HIV infection and transition into an injecting career in this population. Our earlier initiate studies have shown the period shortly after initiation into injection drug use is associated with high risk of HIV infection, especially among young IDUs and women. In Baltimore, we are interested in continuing to understand behaviors around the time of initiation that might be modifiable through intervention, as well as the role of physical/sexual abuse, psychiatric condition, and social networks/social support. Additionally, we are complementing our research with the inclusion of NIUs of whom we will compare and contrast with our new injectors and, observe factors associated with the transition into an injecting career.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Research Project (R01)
Project #
5R01DA011880-05
Application #
6523002
Study Section
Human Development Research Subcommittee (NIDA)
Program Officer
Hartsock, Peter
Project Start
1998-09-30
Project End
2004-08-31
Budget Start
2002-09-01
Budget End
2004-08-31
Support Year
5
Fiscal Year
2002
Total Cost
$380,343
Indirect Cost
Name
Johns Hopkins University
Department
Public Health & Prev Medicine
Type
Schools of Public Health
DUNS #
045911138
City
Baltimore
State
MD
Country
United States
Zip Code
21218
Strathdee, Steffanie A; Beletsky, Leo; Kerr, Thomas (2015) HIV, drugs and the legal environment. Int J Drug Policy 26 Suppl 1:S27-32
White, Kellee; Rudolph, Abby E; Jones, Kandice C et al. (2013) Social and individual risk determinants of HIV testing practices among noninjection drug users at high risk for HIV/AIDS. AIDS Care 25:230-8
Wolfl, Matthias; Rutebemberwa, Alleluiah; Mosbruger, Timothy et al. (2008) Hepatitis C virus immune escape via exploitation of a hole in the T cell repertoire. J Immunol 181:6435-46
Barnes, E; Salio, M; Cerundolo, V et al. (2008) Monocyte derived dendritic cells retain their functional capacity in patients following infection with hepatitis C virus. J Viral Hepat 15:219-28
Rutebemberwa, Alleluiah; Ray, Stuart C; Astemborski, Jacquie et al. (2008) High-programmed death-1 levels on hepatitis C virus-specific T cells during acute infection are associated with viral persistence and require preservation of cognate antigen during chronic infection. J Immunol 181:8215-25
Sherman, Susan G; Cheng, Yingkai; Kral, Alexander H (2007) Prevalence and correlates of opiate overdose among young injection drug users in a large U.S. city. Drug Alcohol Depend 88:182-7
Plitt, Sabrina S; Sherman, Susan G; Viscidi, Raphael P et al. (2007) Human papillomavirus seroprevalence among young male and female drug users. Sex Transm Dis 34:676-80
Bell, Ann V; Ompad, Danielle; Sherman, Susan G (2006) Sexual and drug risk behaviors among women who have sex with women. Am J Public Health 96:1066-72
Ompad, Danielle C; Strathdee, Steffanie A; Celentano, David D et al. (2006) Predictors of early initiation of vaginal and oral sex among urban young adults in Baltimore, Maryland. Arch Sex Behav 35:53-65
Havens, Jennifer R; Sherman, Susan G; Sapun, Marcella et al. (2006) Prevalence and correlates of suicidal ideation among young injection vs. noninjection drug users. Subst Use Misuse 41:245-54

Showing the most recent 10 out of 24 publications